Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrzej Pilc

Showing results (31-40 of 153) with videos related to

Pageof 16
Sort By:
Biological Psychiatry|March 5, 2013
Glutamate-based antidepressants: preclinical psychopharmacologyAndrzej Pilc, Joanna M Wierońska, Phil Skolnick
Rheumatology International|June 25, 2016
Disease activity, quality of life and indirect costs of psoriatic arthritis in PolandPaweł Kawalec, Krzysztof Piotr Malinowski, Andrzej Pilc
Archives of Medical Science : AMS|August 30, 2018
Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysisPaweł Kawalec, Przemysław Holko, Małgorzata Gawin, et al.
Expert Opinion on Investigational Drugs|November 2, 2014
Pregabalin for the treatment of social anxiety disorderPaweł Kawalec, Agnieszka Cierniak, Andrzej Pilc, et al.
Przeglad Gastroenterologiczny|March 25, 2017
Disease activity, quality of life, and indirect costs of ulcerative colitis in PolandPaweł Kawalec, Ewa Stawowczyk, Małgorzata Mossakowska, et al.
Current Neuropharmacology|May 23, 2014
The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysisPaweł Kawalec, Alicja Mikrut, Natalia Wiśniewska, et al.
Brain Research|September 17, 2002
The striatum as a target for anti-rigor effects of an antagonist of mGluR1, but not an agonist of group II metabotropic glutamate receptorsKrystyna Ossowska, Jolanta Konieczny, Andrzej Pilc, et al.
Clinical Rheumatology|July 24, 2013
The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysisPaweł Kawalec, Alicja Mikrut, Natalia Wiśniewska, et al.
Plos One|December 20, 2016
Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in PolandPrzemysław Holko, Paweł Kawalec, Małgorzata Mossakowska, et al.
Expert Opinion on Drug Discovery|June 23, 2020
Developments in the discovery and design of intranasal antidepressantsMałgorzata Panek, Paweł Kawalec, Andrzej Pilc, et al.
Pageof 16

Showing results (31-40 of 153) with videos related to

Sort By:
Pageof 16
Biological Psychiatry|March 5, 2013
Glutamate-based antidepressants: preclinical psychopharmacologyAndrzej Pilc, Joanna M Wierońska, Phil Skolnick
Rheumatology International|June 25, 2016
Disease activity, quality of life and indirect costs of psoriatic arthritis in PolandPaweł Kawalec, Krzysztof Piotr Malinowski, Andrzej Pilc
Archives of Medical Science : AMS|August 30, 2018
Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysisPaweł Kawalec, Przemysław Holko, Małgorzata Gawin, et al.
Expert Opinion on Investigational Drugs|November 2, 2014
Pregabalin for the treatment of social anxiety disorderPaweł Kawalec, Agnieszka Cierniak, Andrzej Pilc, et al.
Przeglad Gastroenterologiczny|March 25, 2017
Disease activity, quality of life, and indirect costs of ulcerative colitis in PolandPaweł Kawalec, Ewa Stawowczyk, Małgorzata Mossakowska, et al.
Current Neuropharmacology|May 23, 2014
The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysisPaweł Kawalec, Alicja Mikrut, Natalia Wiśniewska, et al.
Brain Research|September 17, 2002
The striatum as a target for anti-rigor effects of an antagonist of mGluR1, but not an agonist of group II metabotropic glutamate receptorsKrystyna Ossowska, Jolanta Konieczny, Andrzej Pilc, et al.
Clinical Rheumatology|July 24, 2013
The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysisPaweł Kawalec, Alicja Mikrut, Natalia Wiśniewska, et al.
Plos One|December 20, 2016
Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in PolandPrzemysław Holko, Paweł Kawalec, Małgorzata Mossakowska, et al.
Expert Opinion on Drug Discovery|June 23, 2020
Developments in the discovery and design of intranasal antidepressantsMałgorzata Panek, Paweł Kawalec, Andrzej Pilc, et al.
Pageof 16